Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer, Alliance For Lupus Research To Co-Fund Translational Projects

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer’s partnership with the Alliance for Lupus Research to co-fund translational projects within the context of the pharma’s CTI program is a first. It’s a novel way to speed promising science into the clinic. But can Pfizer, a non-profit research foundation, and academic researchers reconcile their new roles and variant cultures to make the model work?


Related Content

Partnering For Cures: What’s The Equation For Success?
Kyowa Hakko Kirin, Ultragenyx To Develop Treatment For X-linked Hypophosphatemia
Pfizer’s CTI Shows Tangible Signs Of Progress In Its Junior Year
Navigating A Patient Centered World: What Works, What Doesn’t
Pfizer, CFF Focus On Possible Combination Approach To Treating CF’s Underlying Cause
Deals Of The Week: Sun/Dusa; Pfizer/Alliance For Lupus Research; Merck/Regenstrief Institute
Benlysta In GSK’s Hands: A Slow-but-steady Launch, Or A Dud?
Spurred By Necessity, Industry And Academia Are Learning To Share


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts